Hims & Hers Health, Inc.
Close on Oct 19, 2026
- Market cap
- $6.52B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 2, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 10, 2026 | After market close | $753.20M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 11, 2026 | After market close | $608.10M | $-0.40 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 23, 2026 | After market close | $617.80M | $0.08 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 3, 2025 | After market close | $599.00M | $0.06 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 4, 2025 | After market close | $544.80M | $0.17 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 5, 2025 | After market close | $586.00M | $0.20 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 24, 2025 | After market close | $481.10M | $0.11 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 4, 2024 | After market close | $401.60M | $0.32 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 5, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 6, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 26, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 10, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full year 2026 | $275.00M to $325.00M | Lowered |
| Adjusted EBITDAnon-GAAP | third quarter 2026 | $75.00M to $95.00M | New |
| Revenue | full year 2026 | $3.10B to $3.30B | Raised |
| Revenue | third quarter 2026 | $880.00M to $900.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Hims & Hers Health filed with the SEC
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to
Other events · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and
Other events · EX-99.2 to Form 8-K
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers announces strategic shift for US weight loss business
Regulation FD disclosure · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
Results of operations · Other events · EX-99.1 to Form 8-K
Feeling good in your body & mind transforms how you show up in life. That’s why we’re on a mission to help the world feel great through the power of better health. 2 Hims & Hers Q2 2025
Results of operations · Other events · EX-99.2 to Form 8-K
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to
Other events · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering
Other events · EX-99.2 to Form 8-K
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports First Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and
Results of operations · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides First Quarter and Full Year 2022 Outlook
Results of operations · EX-99.1 to Form 8-K
Years Ended December 31, 2020 and 2019
Other events · EX-99.1 to Form 8-K
Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K